SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-037192
Filing Date
2024-03-27
Accepted
2024-03-27 16:13:54
Documents
2
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2230
2 EX-24.1 dyn-ex24_1.htm EX-24.1 11456
  Complete submission text file 0000950170-24-037192.txt   15076
Mailing Address C/O BIOVERATIV INC. 225 SECOND AVENUE WALTHAM MA 02451
Business Address
Cox John (Reporting) CIK: 0001498428 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39509 | Film No.: 24790772

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)